Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSt James's Place Regulatory News (STJ)

Share Price Information for St James's Place (STJ)

Share Price is delayed by 15 minutes
Get Live Data
1,165.00    19.50 (1.70%)
Bid:
1,168.00
Ask:
1,169.00
Spread: 1.00 (0.086%)
Market Cap: £5.93b
STJ Live PriceLast checked at - London Stock Exchange

Intraday St James's Place Share Chart

Director/PDMR Shareholding

25 Oct 2017 09:23

St. James’s Place plc (“SJP”)

SJP was notified on 24 October 2017 of the following changes in SJP shares held by the Executive Directors named below.

SJP Performance Share Plan 2005 (“PSP”) and linked Company Share Option Plan 2010 (“CSOP”)

CSOP

On 26 March 2014 the following Executive Directors (“the Directors”) were awarded a CSOP-linked award, whereby they were granted a nil-cost unapproved option pursuant to the PSP and a linked HMRC-approved CSOP share option:

Andrew Croft, Chief Financial Officer

Ian Gascoigne, Managing Director

David Lamb, Managing Director

The Directors exercised the linked CSOP award on 24 October 2017 with an exercise price of £8.515 per share and, as a result, their linked PSP awards automatically lapsed in respect of the number of shares equal in value to the gain realised upon exercise of the linked CSOP award.

Column 1 sets out the number of SJP shares acquired as a result of the exercise of the linked CSOP award on 24 October 2017, and column 2 sets out the number of SJP shares sold on 24 October 2017 at £11.81 pence per share by the Directors. Column 3 sets out the number of shares that have lapsed under the linked PSP award as a result of these exercises, and Column 4 sets out the number of PSP award shares retained under the linked PSP award.

CSOP 1 2 3 4
Name of Director Number of SJP shares acquired on exercise of CSOP option Number of SJP shares sold Number of SJP shares that have lapsed under the linked PSP award Number of SJP shares retained under the linked PSP award
Andrew Croft 3,054 3,054 853 72,312
Ian Gascoigne 3,054 2,632 853 72,312
David Lamb 3,054 3,054 853 72,312

PSP

On 26 March 2014 the Directors were awarded nil cost unapproved PSP awards. On 24 October 2017 the Directors exercised those awards, as set out in the table below.

Column 1 sets out the number of SJP shares exercised, column 2 sets out the number of SJP shares sold on 24 October 2017 at a price of £11.72 pence per share by the Directors in order to settle income tax and National Insurance liabilities, and column 3 sets out the number of additional SJP shares sold by the Directors at £11.72. Column 4 sets out the number of SJP shares retained.

PSP 1 2 3 4
Name of Director Number of SJP shares exercised Number of SJP shares sold to meet tax liability Number of Additional SJP Shares Sold Number of SJP shares retained
Andrew Croft 72,312 33,987 19,210 19,115
Ian Gascoigne 72,312 33,987 19,210 19,115
David Lamb 72,312 33,987 38,325 0

Following the above transactions, Ian Gascoigne gifted at nil cost 19,537 SJP shares to Gail Gascoigne, a Person Closely Associated with him, on 24 October 2017.

This notification is made in accordance with EU Market Abuse Regulation.

LEI: 213800M993ICXOMBCP87

Classification: 3.1 Additional regulated information required to be disclosed under the laws of a Member State

Deputy Company Secretary, Tel: +44 (0)1285 717237

25 October 2017

View source version on businesswire.com: http://www.businesswire.com/news/home/20171025005470/en/

Copyright Business Wire 2017

Date   Source Headline
1st Sep 20222:08 pmRNSTotal Voting Rights
1st Aug 20223:44 pmRNSBlock listing Interim Review
1st Aug 202211:19 amRNSTotal Voting Rights
28th Jul 20227:00 amRNSHalf-Year/Interim Report
28th Jul 20227:00 amRNSChanges to Board Committee Membership
6th Jul 202212:58 pmRNSHolding(s) in Company
1st Jul 20223:13 pmRNSTotal Voting Rights
1st Jun 20223:36 pmRNSTotal Voting Rights
31st May 202212:41 pmRNSDirector/PDMR Shareholding
26th May 20229:53 amRNSDirector/PDMR Shareholding
20th May 202211:04 amRNSAdditional Listing
19th May 202212:54 pmRNSResult of AGM
5th May 202211:39 amRNSDirector/PDMR Shareholding
3rd May 20223:26 pmRNSTotal Voting Rights
28th Apr 20227:00 amRNSQ1 New Business Inflows and Funds Under Management
21st Apr 20225:10 pmRNS2021 Annual Report and Accounts – Replacement
11th Apr 20223:34 pmRNSAnnual Report & Notice of AGM
1st Apr 202210:42 amRNSTotal Voting Rights
31st Mar 202210:43 amRNSDirector/PDMR Shareholding
30th Mar 20223:06 pmRNSDirector/PDMR Shareholding
28th Mar 20222:43 pmRNSDirector/PDMR Shareholding
8th Mar 20229:35 amRNSAdditional Listing
7th Mar 202210:11 amRNSDirector/PDMR Shareholding
1st Mar 202211:40 amRNSTotal Voting Rights
24th Feb 20227:00 amRNSFinal Results
23rd Feb 20229:31 amRNSHolding(s) in Company
1st Feb 20223:05 pmRNSBlock listing Interim Review
1st Feb 20222:32 pmRNSTotal Voting Rights
27th Jan 20227:00 amRNSDirectorate Change
27th Jan 20227:00 amRNSQ4 New Business Inflows and Funds Under Management
12th Jan 20221:28 pmRNSDirector/PDMR Shareholding
4th Jan 20223:38 pmRNSTotal Voting Rights
20th Dec 202110:14 amRNSChanges to Board Committee Membership
1st Dec 202110:47 amRNSTotal Voting Rights
17th Nov 202112:17 pmRNSDirector Declaration
1st Nov 20214:00 pmRNSDirectorate Change
1st Nov 20213:21 pmRNSTotal Voting Rights
25th Oct 20213:58 pmRNSDirector/PDMR Shareholding
21st Oct 20217:00 amRNSQ3 New Business Inflows and Funds under Management
13th Oct 202110:46 amRNSDirector Declaration
1st Oct 202111:08 amRNSTotal Voting Rights
28th Sep 20211:57 pmRNSHolding(s) in Company
24th Sep 20213:37 pmRNSDirector/PDMR Shareholding
22nd Sep 202110:13 amRNSAdditional Listing
1st Sep 20212:21 pmRNSTotal Voting Rights
24th Aug 20211:43 pmRNSDirector/PDMR Shareholding
6th Aug 20212:58 pmRNSDirector/PDMR Shareholding
2nd Aug 20213:16 pmRNSTotal Voting Rights
2nd Aug 20212:56 pmRNSBlock listing Interim Review
28th Jul 20217:00 amRNSHalf-Year results for the 6 months ended 30 Jun 21

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.